TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06100562

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adapted Dance Program
Description: * Participants will attend a 2x/weekly adaptive dance session for 10 weeks. If participants miss a class due to illness or an unexpected event (loss of transportation, family emergency/need) they will receive a video of the content missed and can complete the session at home.~* Each class will start with a 10 min warm-up that will include stretching and motor games.~* Learn a section of choreography every session using action-based intervention for 30 minutes.~* Break for 5 min.~* Improvisation part of class for 10 min.~* Cool-down for 5 min.
Study: NCT05343754

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hyperbaric oxygen
Description: Hyperbaric treatment will consist of 30 daily treatments in the first 6 weeks of the study, except during the weekends. After compression for 10 minutes patients will receive 80minutes (4 times 20 minutes) 100% O2 with 3 airbrakes (21% O2) of 5 minutes at 2.4-2.5 ATA, and then 10 minutes decompression with the first part of decompression till 0.3 ATA with 100% oxygen (this will usually take seven minutes). The last 0.3 ATA will be decompressed with air. In total one hyperbaric session will be 110 minutes. Treatment will start directly at the beginning of the study.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: In order to compare efficacy, patients that do not wish to undergo hyperbaric treatment, will serve as a control group. At baseline they will be asked for the reason they do not wish to undergo hyperbaric treatment. All patients and controls will be asked to report pain scores using a numeric pain rating scale (NRS) and quality of life (Wound-Q) questionnaires. They will continue to receive standard care as deemed necessary by their primary physician.
Study: NCT06219694

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser Acupuncture
Description: Laser stimulation energy of 4.5 J for 30 seconds at each of the following acupoints: bilateral Cuanzhu (BL2), Fengchi (GB20), Taiyang (EX-HN5), Shuaigu (GB8), Hegu (LI4), Taichong (LR3) and midline Yintang (EX-HN3)

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Sham treatment with no laser output, stimulate the same acupoints as laser acupuncture group as follows: 30 seconds at bilateral Cuanzhu (BL2), Fengchi (GB20), Taiyang (EX-HN5), Shuaigu (GB8), Hegu (LI4), Taichong (LR3) and midline Yintang (EX-HN3)~After 6 months followed up, the sham group received truely Laser stimulation energy of 4.5 J for 30 seconds at each of the following acupoints: bilateral Cuanzhu (BL2), Fengchi (GB20), Taiyang (EX-HN5), Shuaigu (GB8), Hegu (LI4), Taichong (LR3) and midline Yintang (EX-HN3), and followed up for another 3 months.
Study: NCT05876689

Intervention type: DEVICE
Intervention: DREAM OCT
Description: Swept Source OCT (similar to Zeiss Plex Elite)
Study: NCT06542029

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Groups 4 Health (G4H)
Description: Groups 4 Health, G4H, (Ryhmät kuntoon) at the University of Helsinki is a manualized group intervention for the students that focuses on social connectedness and aims at improving general health and life satisfaction. G4H groups are facilitated by two psychology MA students (or licensed psychologists) carefully trained for the intervention and mentored by experienced clinical psychologists. G4H consists of five 90 minutes sessions that aim to give participants the knowledge and skills they need to effectively manage their social group memberships and identities. Each session contains exercises and discussions described in the G4H workbook that target different aspects of group life identified within the social identity model of identity change and put the Social Identity Approach to Health -model to practice. Students earn 2 ECTS (European Credit Transfer and Accumulation System) credits for completing the intervention.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: The study psychologists' group intervention
Description: University of Helsinki study psychology team organizes group interventions for various challenges of studying for bachelor's and master's students. These groups offer client-centered peer support facilitated by one to two study psychologists. Recurring themes in the groups include: challenges in attentiveness, independent studying, and scientific writing, as well as support for re-entering the studies after a break. The approach in the different thematic groups is largely similar: short presentations, group discussions and practices. These groups have been implemented as both face-to-face and remote meetings. One group typically lasts for a study period and comprises five to six 90 minutes sessions. Typical group size is six to 12 students.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Towards better well-being and studying -online course
Description: Towards better well-being and studying -online course (Kohti parempaa opiskelua) is an optional, seven-week online course that aims to foster university students' well-being and study skills. It is available for all University of Helsinki students. The course is based on principles of Acceptance and Commitment therapy and aims to support the development of psychological flexibility. The course takes place in Moodle platform and the students earn 3 ECTS credits for completing it. This course progresses week by week and has six central themes which include individual work in practicing psychological flexibility skills as well as study skills on a weekly basis and weekly group discussion.
Study: NCT05687604

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: multiple behavior change therapy
Description: goals related to their physical activity, smoking, and/or obesity, and will be asked to meet those goals weekly/daily. Participants will also be asked to record their weight, activity, and/or cigarette smoking daily, and will complete 16 telehealth sessions with study staff across the 12 months of the study. Will have physical measures taken or extracted from the medical record at baseline, 3 months, 6 months, and 12 months.
Study: NCT06314711

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ultrasound
Description: High-frequency ultrasound of ex vivo specimen
Study: NCT06437301

Intervention type: OTHER
Group type: OTHER
Intervention: Baseline measure of ETCO2 without mask
Description: Baseline

Intervention type: OTHER
Group type: OTHER
Intervention: Baseline ETCO2 with mask
Description: Mask

Intervention type: OTHER
Group type: OTHER
Intervention: ETCO2 after 200 meter walk with mask
Description: 200 meter walk and mask

Intervention type: OTHER
Group type: OTHER
Intervention: ETCO2 after 200 meter walk without mask
Description: 200 meter walk
Study: NCT06262152

Intervention type: DIAGNOSTIC_TEST
Intervention: Actigraphy, blood and salivary sample, and sleep evaluation
Description: * For each subject, one 4 mL blood and one 2 mL saliva samples will be collected at each assessment.~* 7 days actigraph recording through wearing of Actiwatch spectrum plus at home~* Standardized sleep questionnaire administration
Study: NCT05441384

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Caregiver - Fear Of Recurrence Therapy (FC-FORT)
Description: 7 weekly sessions of 90-120 minutes each. During the 7 weeks, participants will be asked to participate in activities, participate in group discussions, and complete homework assignments.
Study: NCT06577363

Intervention type: DRUG
Intervention: Maribavir
Description: Maribavir tablets
Study: NCT05816811

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Power-focused resistance training
Description: Participants will undergo 10 weeks of power-focused resistance training.
Study: NCT05454033

Intervention type: DEVICE
Group type: OTHER
Intervention: JUVÉDERM® VOLITE™
Description: Injection, intradermal

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: JUVÉDERM® VOLITE™
Description: Injection, intradermal

Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: No-treatment control
Study: NCT04912583

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High tidal volume
Description: A high tidal volume (14-16 ml/kg pbw) with positive end-expiratory pressure will be applied during mechanical ventilation.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Low tidal volume
Description: A low tidal volume (8-10 ml/kg pbw) with positive end-expiratory pressure will be applied during mechanical ventilation.
Study: NCT06546163

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Baseline survey
Description: Baseline surveys contains a series of scaled questions, including sociodemographic variable (age, sex, etc), profile of mood states, perceived stress scale, Eating Loss of Control scale, Eating Disorder Examination Questionnaire, Brief Resilience Scale- BRS,Heart Rate Variability and coherence measures

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Baseline survey
Description: Baseline surveys contains a series of scaled questions, including sociodemographic variable (age, sex, etc), profile of mood states, perceived stress scale, Eating Loss of Control scale, Eating Disorder Examination Questionnaire, Brief Resilience Scale- BRS,Heart Rate Variability and coherence measures

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Heart rate variability biofeedback
Description: Participants randomized to the intervention arm will receive a standardized HRV sensor and accompanying smartphone app, and a 30-minute HRVB training to use the biofeedback signals to generate a resonant frequency pattern of HRV (coherence) after collecting data at baseline in person. Participants will be asked to practice their HRVB skills at home for 10 minutes for two weeks.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Educational materials
Description: Participants randomized to the waitlist control arm will receive educational materials on eating disorders and stress management and will be sent home with these materials after completing the baseline survey. They will be encouraged to read the materials over the next two weeks before coming in for T2 survey.
Study: NCT05202808

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Light Adjustable lens (LAL) and Light Delivery Device (LDD)
Description: Experimental treatment group will receive Light adjustable lens with Light delivery Device treatments

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control IOL
Description: Control treatment group will receive a Control IOL
Study: NCT05123872

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS
Description: trancranial direct current stimulation 30 sessions within 6 weeks (treatment on working days) 2mA with cathode on the right and anode an the left side
Study: NCT06379789

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGV131
Description: Single dose administered via intravenous (IV) infusion before LNP1265

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGV131
Description: Single dose administered via intravenous (IV) infusion before LNP1265

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGV131
Description: Single dose administered via intravenous (IV) infusion before LNP1265

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGV131
Description: Single dose administered via intravenous (IV) infusion before LNP1265

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGV131
Description: Single dose administered via intravenous (IV) infusion before LNP1265

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGV131
Description: Single dose administered via intravenous (IV) infusion before LNP1265

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGV131
Description: Single dose administered via intravenous (IV) infusion before LNP1265
Study: NCT06116955

Intervention type: DRUG
Intervention: Midazolam and sufentanil
Description: Patients undergoing bronchoscopic diagnosis and treatment under moderate sedation with midazolam combined with sufentani.

Intervention type: DRUG
Intervention: Midazolam, sufentanil and propofol
Description: Patients undergoing bronchoscopic diagnosis and treatment under deep sedation with midazolam and sufentani combined with propofol.
Study: NCT06379789

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LNP1265
Description: Single dose administered via IV infusion following REGV131

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LNP1265
Description: Single dose administered via IV infusion following REGV131

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LNP1265
Description: Single dose administered via IV infusion following REGV131

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LNP1265
Description: Single dose administered via IV infusion following REGV131

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LNP1265
Description: Single dose administered via IV infusion following REGV131

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LNP1265
Description: Single dose administered via IV infusion following REGV131

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LNP1265
Description: Single dose administered via IV infusion following REGV131
Study: NCT00588926

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remifentanil
Description: After the mapping electrode is in situ, recording of baseline electrical activity is done for two-three minutes and an infusion of Remifentanil, 0.1 microgram per kilogram per minute is started. This procedure continues for a few minutes until the patient is sedated and then the infusion is stopped and the patient allowed to recover. The recordings continue during the whole procedure.
Study: NCT05062655

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Drug reconciliation
Description: Drug reconciliation information transmission to pharmacist interview with the patient
Study: NCT06276062

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Distal radius fracture fixation in pediatrics.
Description: using double short titanium elastic nails in treatment of pediatric distal radius fractures.
Study: NCT05403996

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Activa-Mente
Description: Active break program
Study: NCT05252546

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pyrotinib tablet
Description: single oral dose of pyrotinib or co-administered with Montmorillonite Power or Loperamide

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Montmorillonite Power
Description: 3 g or one pouch of montmorillonite power 2 hours after pyrotinib administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Loperamide
Description: 4 mg of loperamide with pyrotinib followed by 2mg every 2 hours for 2 times for a total of 8mg/day
Study: NCT06116955

Intervention type: DRUG
Intervention: Remazolam and sufentanil.
Description: Patients undergoing bronchoscopic diagnosis and treatment under moderate sedation with remazolam combined with sufentani.

Intervention type: DRUG
Intervention: Remazolam, sufentanil and propofol
Description: Patients undergoing bronchoscopic diagnosis and treatment under deep sedation with remazolam and sufentani combined with propofol.
Study: NCT05110872

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cigarette flavor restricted and e-cigarette flavor restricted
Description: 1. Tobacco cigarettes will be available in the Experimental Tobacco Marketplace~2. Tobacco-flavored e-cigarettes will be available in the Experimental Tobacco Marketplace

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cigarette flavor restricted and e-cigarette flavor restricted
Description: 1. Tobacco cigarettes will be available in the Experimental Tobacco Marketplace~2. Tobacco-flavored e-cigarettes will be available in the Experimental Tobacco Marketplace

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cigarette flavor restricted and e-cigarette flavor unrestricted
Description: 1. Tobacco cigarettes will be available in the Experimental Tobacco Marketplace~2. Tobacco-flavored and a range of flavored e-cigarettes will be available in the Experimental Tobacco Marketplace

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cigarette flavor restricted and e-cigarette flavor unrestricted
Description: 1. Tobacco cigarettes will be available in the Experimental Tobacco Marketplace~2. Tobacco-flavored and a range of flavored e-cigarettes will be available in the Experimental Tobacco Marketplace

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cigarette flavor unrestricted and e-cigarette flavor restricted
Description: 1. Tobacco and menthol cigarettes will be available in the Experimental Tobacco Marketplace~2. Tobacco-flavored e-cigarettes will be available in the Experimental Tobacco Marketplace

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cigarette flavor unrestricted and e-cigarette flavor restricted
Description: 1. Tobacco and menthol cigarettes will be available in the Experimental Tobacco Marketplace~2. Tobacco-flavored e-cigarettes will be available in the Experimental Tobacco Marketplace

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cigarette flavor unrestricted and e-cigarette flavor unrestricted
Description: 1. Tobacco and menthol cigarettes will be available in the Experimental Tobacco Marketplace~2. Tobacco-flavored and a range of flavored e-cigarettes will be available in the Experimental Tobacco Marketplace

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cigarette flavor unrestricted and e-cigarette flavor unrestricted
Description: 1. Tobacco and menthol cigarettes will be available in the Experimental Tobacco Marketplace~2. Tobacco-flavored and a range of flavored e-cigarettes will be available in the Experimental Tobacco Marketplace
Study: NCT04090918

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac examination programme 3 months after abdominal surgery
Description: Blood- and urine sampling, electrocardiogram, wavECG (Myovista), transthoracic echocardiography, Finapres, cardiac magnetic resonance imaging

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac examination programme 3 months after abdominal surgery
Description: Blood- and urine sampling, electrocardiogram, wavECG (Myovista), transthoracic echocardiography, Finapres, cardiac magnetic resonance imaging
Study: NCT05400291

Intervention type: DIAGNOSTIC_TEST
Intervention: Chondroitin Sulfate Staining
Description: Staining of histopathological slides

Intervention type: DIAGNOSTIC_TEST
Intervention: Chondroitin Sulfate Staining
Description: Staining of histopathological slides
Study: NCT05271981

Intervention type: OTHER
Intervention: Retrospective data collection
Description: Data collection from the medical file of the patients

Intervention type: OTHER
Intervention: Phone interview
Description: Call for collecting fertility data and obstetrical issues of the patients
Study: NCT06269224

Intervention type: OTHER
Intervention: Participants were recreational runners who run between 20 to 50 km weekly; each one has 35 runners.
Description: The Myoton device was used over the Latissimus Dorsi (LD) muscle on both dominant and nondominant sides to measure muscle tone (Hz), elasticity, and stiffness (N/m) values. Trunk flexibility and flexibility of lumbar extensor muscles were measured with tape measurement (cm). The trunk range of motion (ROM, ˚) was measured using goniometer. Thoracolumbar Fascia Length Test and Modified Schober Test were used for thoracolumbar (TLF) fascia flexibility. The weekly training distance (km), duration (h) and daily water consumption (lt) rates were recorded. The percentage of individuals experiencing lower extremity injuries and lower back pain within the RSM group was calculated.
Study: NCT06026384

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: text in non-narrative form
Description: Participants will be asked to read a text and give feedback afterwards

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: text in narrative form
Description: Participants will be asked to read a text and give feedback afterwards

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: animated video in non-narrative form
Description: Participants will be asked to watch a video and give feedback afterwards

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: animated video in narrative form
Description: Participants will be asked to watch a video and give feedback afterwards
Study: NCT05588336

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine
Description: In the literature, intrathecal morphine doses were applied according to the patients' actual body weight and there is no study comparing intrathecal morphine dose in thoracic surgery patients.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine
Description: In the literature, intrathecal morphine doses were applied according to the patients' actual body weight and there is no study comparing intrathecal morphine dose in thoracic surgery patients.
Study: NCT05587270

Intervention type: OTHER
Intervention: Web based surveys
Description: A web-based survey will explain the purpose, aims, and ethical rights, as well as how to complete the questionnaire online. Further, information about, and an invitation to participate in the DXA-scan will be included with this information. Upon electronic consent by both parent and athlete (or just athlete if of consenting age (15 y o a)), access to the multi-section questionnaire will be granted. Contact details of the researchers will be available in case of difficulties comprehending the questions. Following completion, the participants' data will be sent to a secure database for analysis. Participants will be ensured of the confidentiality of the study and will be free to withdraw from the study. Parents will also be asked to provide their consent if participants age is under 14.

Intervention type: OTHER
Intervention: Web based surveys
Description: A web-based survey will explain the purpose, aims, and ethical rights, as well as how to complete the questionnaire online. Further, information about, and an invitation to participate in the DXA-scan will be included with this information. Upon electronic consent by both parent and athlete (or just athlete if of consenting age (15 y o a)), access to the multi-section questionnaire will be granted. Contact details of the researchers will be available in case of difficulties comprehending the questions. Following completion, the participants' data will be sent to a secure database for analysis. Participants will be ensured of the confidentiality of the study and will be free to withdraw from the study. Parents will also be asked to provide their consent if participants age is under 14.

Intervention type: RADIATION
Intervention: DXA
Description: All participants will be invited to complete a DXA scan at baseline. DXA is to date the most reliable way of examining the long-term physical consequences of RED-S.